Clinical Use of [TIMP-2]•[IGFBP7] Biomarker Testing to Assess Risk of Acute Kidney Injury in Critical Care: Guidance From an Expert Panel
Critical Care - United Kingdom
doi 10.1186/s13054-019-2504-8
Full Text
Open PDFAbstract
Available in full text
Date
June 20, 2019
Authors
Publisher
Springer Science and Business Media LLC